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Abstract
Background: Aortic valve stenosis is a common finding diagnosed with high sensitivity in transthoracic
echocardiography, but the examiner often finds himself confronted with uncertain results in patients with
moderate pressure gradients and concomitant systolic heart failure. While patients with true-severe low-gradient aortic
valve stenosis with either reduced or preserved left ventricular systolic function are primarily candidates for valve
replacement, there is a relevant proportion of patients with pseudo-severe aortic valve stenosis anticipated not to
benefit but actually rather deteriorate by interventional therapy or surgery.
Case presentation: In this article we present a case report of a male patient with pseudo-severe aortic valve stenosis
due to cardiac amyloidosis highlighting the diagnostic schedule. The patient underwent stress echocardiography
because of discrepant findings in transthoracic echocardiography and cardiac catheterization regarding the severity
of aortic valve stenosis. After evaluation of the results, it became clear that he had a need for optimum heart failure
medication and implantation of a cardiac resynchronization therapy defibrillator.
Conclusion: Due to the pitfalls in conventional as well as invasive diagnostics at rest, Stress echocardiography should
be considered part of the standard optimum diagnostic spectrum in all unclear or borderline cases in order to confirm
the correct diagnosis and constitute optimal therapy.
Keywords: Aortic valve stenosis (AS), Cardiac amyloidosis, Dobutamine stress echocardiography, Low-gradient AS,
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Background
Stenosis of the aortic valve (AS) is the most common
valvular disease in elderly persons today. Previous studies
have reported prevalence for moderate or severe AS of 5–
8% in a population older than 74 years [1, 2]. While
current guidelines recommend conservative medical treat-
ment in patients with mild and moderate AS [3], severe
AS is highly recommended for surgical treatment espe-
cially in symptomatic patients, because of the poor prog-
nosis of this disease entity in patients under conservative
therapy [3, 4]. In elderly patients ≥80 years with severe
AS, 3-year mortality has been described to be approxi-
mately 40% [5].
The diagnostic cornerstone in the differentiation be-
tween moderate and severe AS is transthoracic echocar-
diography. By convenient use of this widely available,
non-invasive, and cost saving imaging technique, the
experienced echocardiographer is able to determine the
transvalvular pressure gradients and calculate the valve
area with high diagnostic accuracy in most patients [3].
However, diagnostic accuracy can be considerably di-
minished in certain patients. This particularly refers to
patients with a decreased left-ventricular-ejection-frac-
tion (LVEF), occasionally leading to low transvalvular
pressure gradients even if the opening area of the valve
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is indeed severely restricted, as e.g. confirmed by trans-
esophageal echocardiography, usually referred to as low-
gradient AS [6]. On the other hand, an echocardiogra-
phically confirmed severely diminished aortic valve
opening area in this patient group might also be func-
tional due to the profoundly reduced LV stroke volume
leading to incomplete opening of the aortic valve, usually
referred to as pseudo-severe AS [7]. Some patients may
also have low aortic valve pressure gradient and severe
AS, but preserved LVEF [8]. This so called paradoxical
low-flow, low gradient AS is particularly difficult to diag-
nose and standard diagnostics often lead to false results
and inadequate therapy [9]. While conclusive differenti-
ation of the before mentioned disease entities is highly
important for therapy planning in this patient group
with high procedural risk during aortic valve replace-
ment (AVR), it often represents a diagnostic dilemma for
the cardiologist particularly in case of combined valvular
diseases or myocardial comorbidities since even invasive
measurements are often inconclusive in such cases.
Case presentation
An 82 year old male patient was referred to our cardio-
logical department for treatment of aortic valve stenosis.
The patient was in substantially reduced general condi-
tion with dyspnoe on insignificant loads (NYHA III) and
edemas of hands and feet. Physical examination revealed
a grade 3/6 systolic ejection murmur with radiation to
the carotid arteries. There had been multiple hospitaliza-
tions in the past 6 month because of recurrent cardiac
decompensations. Previously known comorbidities were
chronic heart failure for unknown reason, atrial fibrillation,
pulmonary hypertension and chronic obstructive pulmon-
ary disease. Cardiovascular risk factors were arterial hyper-
tension, diabetes, and former nicotine abuse. Biochemical
tests revealed a moderately decreased glomerular filtration
rate (54 ml/min/1.73qm), slightly increased creatinine
(1.35 mg/dl) and increased high sensitivity troponin
(98.5 pg/ml). NT-proBNP was 5473 pg/ml.
The patient underwent transthoracic echocardiography
for staging severity of the aortic valve stenosis, which re-
vealed borderline results (peak aortic jet velocity 2.8 m/
s, mean aortic jet velocity 2.1 m/s, peak aortic pressure
gradient 31 mmHG, mean aortic pressure gradient 19
mmHG, calculated aortic valve area 0.9 cm2). Global left
ventricular systolic function was highly reduced (LVEF
Simpson 4CH = 29%), stroke volume index was 24 ml/
qm. Global longitudinal strain was -7.3%. Apical sparing,
which could be a sign for cardiac amyloidosis [10] was
not present. Transthoracic echocardiography also re-
vealed diastolic dysfunction (e = 1.01 m/s; e’ septal =
0.03 m/s; e’lateral = 0.04 m/s; s’septal 0.02 m/s; s’lateral
= 0.03 m/s, e/e’ = 28.9). The left atrium was moderately,
and the right atrium profoundly enlarged (35 cm2 each,
left atrial volume index 67.8 ml/qm). Chest X-ray
showed a global enlarged heart, chronic pulmonary con-
gestion, and right-sided pleural effusion (Fig. 1). Coron-
ary angiography showed no significant coronary artery
stenosis. Laevocardiography confirmed a highly reduced
LVEF and a massively increased left ventricular end-
diastolic pressure (33 mmHg), Right heart catheterization
showed a normal cardiac output at rest (cardiac index 3.1 l/
min*m2) and post-capillary pulmonary hypertension (pul-
monary artery mean pressure 44 mmHG, max 66 mmHg,
pulmonary capillary wedge pressure 35 mmHG). Invasively
measured aortic valve gradients were 25/16 (max/mean)
mmHG and the aortic valve opening area was calculated as
1.9 cm2. In transesophageal echocardiography, the opening
area of the aortic valve was planimetrically determined as
0.8 cm2, again indicating severe AS (Fig. 2).
Due to discrepant findings in echocardiography and
cardiac catheterization regarding the severity of aortic
valve stenosis, low-dose dobutamine stress echocardiog-
raphy was performed (Fig. 3). At rest conditions, there
was global hypokinesia with an ejection fraction of 33%.
Aortic valve (AV) mean pressure was 16 mmHg refer-
ring to a calculated aortic valve opening area of 0,7 cm2.
Under peak dobutamine stress (20 mcg/kg/min), LVEF
increased to 47% mean and mean AV pressure gradient
to 23 mmHg. Left ventricular outflow tract velocity in-
creased more than aortic valve velocity (LVOT/AV 0.2 at
rest vs. 0.25 under stress) referring to an enlarged open-
ing area of the aortic valve under stress conditions from
0.7 cm2 to 1.1 cm2. Stroke volume increased by 61.3% to
50 ml. On the basis of these diagnostic findings, AS was
classified as pseudo-severe due to systolic dysfunction of
the left ventricle with preserved contractile reserve, indi-
cating a non-valvular reason for heart-failure and no
indication for valve replacement.
Fig. 1 Chest X-ray depicting a global enlarged heart, chronic pulmonary
congestion, and right-sided pleural effusion
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Since the origin of the highly reduced LVEF was still
unclear, cardiac MRI was performed, confirming global
hypokinesia with a LVEF of 35% and revealing reduced
myocardium-to-blood contrast, raising suspicion for
presence of a cardiomyopathy (Fig. 4). An endomyocar-
dial biopsy from the intraventricular septum in the right
ventricular outflow tract was done, revealing multifocal
interstitial transthyretin- related cardiac amyloidosis
(ATTR). Because of a newly developed complete left
bundle branch block in the ECG (Fig. 5) and the severely
reduced LVEF, implantation of a cardiac resynchronization
therapy defibrillator (CRT-D), was performed on top of
optimum heart failure medication. Regrettably, at short-
and medium-term follow-up echocardiography, LVEF did
not show relevant improvement, although no signs of car-
diac dyssynchrony could be found. However, NYHA im-
proved to NYHA II and in the following 2-year period
after device implantation, no more hospitalizations were
required. Status of AS in follow-up transthoracic echocar-
diography 1 year later did not differ from baseline.
Discussion and conclusions
This clinical case highlights the potential value of dobu-
tamine stress echocardiography in anticipated low-grade
true-severe AS. After the initial echocardiography show-
ing low LVEF, a mean valvular gradient <40 mmHg and
a calculated valve area <1 cm2, the patient was suspected
to have low-flow, low-gradient aortic stenosis [3]. This
disease entity would normally lead to valve replacement
because of the potential benefits in terms of symptoms
and survival gained from this procedure [3, 11], but
should also be assessed very carefully when planning
valve replacement. The American College of Cardiology
recommends AVR for “symptomatic patients with severe
Fig. 2 Morphologic aspect of the aortic valve in transesophageal echocardiography. Aortic valve area is calculated as 0.85 cm2 by planimetry
Fig. 3 a Stress echocardiography at rest conditions. AV mean pressure
is calculated as 16 mmHg. b Under stress conditions (20 gamma
dobutamine), AV mean pressure did not exceed 23 mmHg
Salinger et al. BMC Cardiovascular Disorders  (2017) 17:86 Page 3 of 6
AS and decreased systolic opening in calcified or con-
genitally stenotic aortic valves and an aortic velocity of
>4.0 m/s or greater, or a mean pressure gradient of
40 mmHg or higher and symptoms of heart failure” [11].
However, in particular patients without contractile re-
serve have been shown to have exceedingly high opera-
tive mortality [12]. Differentiation between patients with
low-flow, low-gradient stenosis and those with pseudo-
severe stenosis can be very difficult in clinical practice
since echocardiographic characteristics might differ only
marginally at rest between both groups. Dobutamine
stress echocardiography was first used as early as 1995
to distinguish these two subgroups. Based on the results
from this study, it was already speculated that a broader
use of this method might be clinically useful [13]. In
2001 it was first shown that clinical management of
individuals with aortic stenosis and left ventricular dys-
function as well as low or intermediate valve gradients
can indeed be improved by dobutamine stress echocardi-
ography, because not only the distinction between pa-
tients with severe and non-severe aortic stenosis is
improved, but this has indeed relevant implications on
clinical outcome [14]. True-severe low-flow, low-gradient
stenosis patients primarily benefit from AVR, since the
valve itself is the main problem, whereas the primary
pathology in pseudo-severe stenosis is located in the myo-
cardium, requiring intensified conservative or specialized
treatment based on the underlying disease [15].
In the present case, aortic stenosis of our patient could
be clearly classified pseudo-severe by low dose dobuta-
mine stress echocardiography. In the respective guidelines
of the European Society of Cardiology, this procedure is
not well established, but mentioned as potentially useful
for the aforesaid diagnostic indication [3]. It is a widely-
used, non-invasive method that can be done not only in-
hospital but also in ambulatory patient care. Examination
time is actually short and procedural risk has shown to be
low [13]. Therefore, the net benefit greatly outweighs
potential patient risks, justifying the investment in cases
similar to the one described above.
Following stress-echocardiography, we performed car-
diac MRI to reveal the origin of high-grade systolic dys-
function in our patient, revealing typical signs of an
infiltrative cardiomyopathy such as late gadolinium en-
hancement [16] and dilated atria as well as a thickened
septum and global left ventricular hypertrophy. High
sensitive troponin was checked and turned out to be ele-
vated. This serum biomarker has been shown to be a
useful but non-specific diagnostic tool in various heredi-
tary or secondary cardiomyopathies such as e.g. Sarcoid-
osis or Anderson-Fabry disease [17, 18]. In the described
case, the final diagnosis ultimately clarifying the etiology
of the pathological myocardial findings was made by
endomyocardial biopsy from the right ventricle. Histo-
logical findings clearly revealed cardiac amyloidosis.
Amyloidosis is a systemic disease which can affect every
organ, but especially cardiac involvement is a major deter-
minant in patients prognosis [19]. In general, amyloidosis
is considered a rare disease. However, there is a high prob-
ability of under-diagnosis particularly in elderly patients,
where specific symptoms can be easily misinterpreted as
an expression of advanced aging processes. Different stud-
ies have also shown that Amyloidosis and AS may occur
together in a significant number of patients [20–23].
Today, several diagnostic tools are available to rule out
whether a patient is indeed affected by cardiac amyloid-
osis, including the ECG, serum biomarkers, echocardiog-
raphy, MRI and nuclear medicine imaging techniques
[24, 25]. In cases where additional advanced imaging
techniques are not available, standard echocardiographic
Fig. 4 a Native MRI, 4-chamber view, showing enlarged atria und
left ventricular hypertrophy (LA 40 mm2; RA 41 mm2, lateral wall
thickness 14 mm; septal wall thickness 16 mm) as signs of cardiac
amyloidosis. b Morphologic aspect of the left ventricular outflow
tract and aortic valve in MRI
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examinations can be expanded by speckle tracking ana-
lysis of left ventricular (systolic) function [26]. However,
in order to come to a definite diagnosis, current guide-
lines recommend endomyocardial biopsy [27]. Guide-
lines for therapy also recommend intensified heart
failure therapy in respective patients with mainly sys-
tolic dysfunction. However, the impact of device ther-
apy such as CRT-D on top of medical therapy on
symptoms and prognosis in cardiac amyloidosis is cur-
rently not well investigated.
The presented case highlights some important aspects
and pitfalls in diagnosis and treatment of elderly patients
with aortic valve stenosis transferred to hospital for aortic
valve replacement. While the natural history of low-
gradient aortic valve stenosis and concept of optimum
therapy including valve replacement is generally better
understood today, great care has to be taken not to exag-
gerate these findings to patients with pseudo-severe aortic
valve stenosis. Stress echocardiography should be consid-
ered part of the standard optimum diagnostic spectrum in
all unclear or borderline cases in order to confirm the
correct diagnosis and constitute optimal therapy.
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